M. Hermsmeier

发表

Prospective identification of biologically active structures by topomer shape similarity searching.

R. Cramer, M. Poss, M. Hermsmeier, 1999, Journal of medicinal chemistry.

Diversity assessment.

J. Mason, M. Hermsmeier, 1999, Current opinion in chemical biology.

Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist.

Ping Chen, S. Spergel, S. Chong, 2003, Journal of medicinal chemistry.

Are target-family-privileged substructures truly privileged?

Dora M Schnur, Andrew J Tebben, D. Schnur, 2006, Journal of medicinal chemistry.

Synthesis, pharmacology, and molecular modeling studies of semirigid, nicotinic agonists.

M. Hermsmeier, C. Spivak, T. Gund, 1988, Journal of medicinal chemistry.

Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR.

J. Barrish, M. Hermsmeier, E. Gordon, 1994, Journal of medicinal chemistry.

Solid-phase synthesis of 5-substituted amino pyrazoles.

M. Poss, M. Hermsmeier, C. Cooper, 2005, Journal of combinatorial chemistry.

Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicity.

S. Spergel, O. Kocy, J. Barrish, 1996, Journal of medicinal chemistry.

α-hydroxyamide derived aminodiols as potent inhibitors of hiv protease

Ping Chen, S. Spergel, J. Barrish, 1995 .

Crystal Structures of Monensin B Lithium and Silver Salts.

D. Walba, M. Hermsmeier, R. Haltiwanger, 1986 .

Crystal structures of monensin B lithium and silver salts

D. Walba, M. Hermsmeier, R. Haltiwanger, 1986 .

Trends in kinase selectivity: insights for target class-focused library screening.

Stephen R. Johnson, Stephen R Johnson, Wayne Vaccaro, 2011, Journal of medicinal chemistry.

Binary Formal Inference-Based Recursive Modeling Using Multiple Atom and Physicochemical Property Class Pair and Torsion Descriptors as Decision Criteria

Sung Jin Cho, C. Frank Shen, Mark A. Hermsmeier, 2000, J. Chem. Inf. Comput. Sci..

Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor

J. Barrish, M. Hermsmeier, R. Colonno, 1995, Journal of virology.

Genetic Algorithm Guided Selection: Variable Selection and Subset Selection

Sung Jin Cho, Mark A. Hermsmeier, M. Hermsmeier, 2002, J. Chem. Inf. Comput. Sci..

Measuring CAMD technique performance: A virtual screening case study in the design of validation experiments

Andrew C. Good, Mark A. Hermsmeier, Sally A. Hindle, 2004, J. Comput. Aided Mol. Des..

Shape group studies of molecular similarity: relative shapes of Van der Waals and electrostatic potential surfaces of nicotinic agonists

Gustavo A. Arteca, Paul G. Mezey, Mark Hermsmeier, 1988 .

Comparison between Ab Initio and semiempirical net atomic charges of some nicotinic acetylcholine receptor agonists

M. Hermsmeier, T. Gund, J. Yadav, 2009 .

Conformational properties of the THYME polyethers. The bis-THYME cylinder: a three-dimensional analog of 18-crown-6

D. Walba, M. Hermsmeier, R. Haltiwanger, 1987 .

Measuring CAMD Technique Performance, 2. How "Druglike" Are Drugs? Implications of Random Test Set Selection Exemplified Using Druglikeness Classification Models

Andrew C. Good, Mark A. Hermsmeier, A. Good, 2007, J. Chem. Inf. Model..

Design and synthesis of nonpeptidal endothelin receptor antagonists based on the structure of a cyclic pentapeptide

M. Hermsmeier, N. Murugesan, Z. Gu, 1995 .

Testing non-additivity of biological activity in a combinatorial library.

C. F. Shen, M. Poss, M. Hermsmeier, 2002, Combinatorial chemistry & high throughput screening.